Pioneering a full-ecosystem microbiota approach to improve survival outcomes in life-threatening diseases
9
The human gut contains the largest ecosystem of microbial species having complex host-microbiome interactive networks that contribute to our physiology and regulate our immune system. An imbalance in this host-microbiome interaction is associated with disease and the ability to restore or stabilise the network by introducing a rich and diverse cocktail of microbial species can play a vital role in treating diseases. French biotech company, MaaT Pharma, has developed a differentiated approach to re-establish the full diversity of microbial species in the gut using its standardised, full-ecosystem microbiome restoration biotherapeutics and is expanding this approach with a breakthrough fermentation technology.